Legend Announces FDA clearance of IND application on CAR-T immuno-cell therapy for the Treatment of Multiple …PR Newswire (press release)LCAR-B38M (JNJ-68284528) is an autologous CAR-T therapy that targets B cell Maturation Antigen (BCMA), a molecule… Continue reading
Janssen Announces Initiation of Phase 1b/2 Clinical Development Program Evaluating JNJ-68284528 CAR-T Cells for …PR Newswire (press release)The primary objective of the Phase 1b portion of the study is to characterize the safety and establish the dos… Continue reading
GeekWireBiomanufacturing company AbSci raises $12M to scale synthetic biology platformGeekWireThe AbSci platform is composed of two products: SoluPro, a synthetic biology platform based on genetically engineered E. coli, and purification platform Soul… Continue reading
Genetic Literacy Project |
First Luxterna results: Does the $850000 gene therapy work?
Genetic Literacy Project About eight weeks earlier, [Jack Hogan had] been the first person to get an $850,000 therapy called Luxturna since it had hit the market. It was intended to replace a mutant gene in Jack’s retinal cells that impaired his vision. … [Jack’s mother … |
CBS News |
Woman says experimental stem cell procedure for eye disease was “too good to be true”
CBS News The federal government is cracking down on what it describes as “unscrupulous” stem cell clinics selling unapproved treatments for eye problems like macular degeneration. Many people with fading vision have turned to stem cell therapy, believing it’s … |
CBS News |
Woman says experimental stem cell procedure for eye disease was “too good to be true”
CBS News The federal government is cracking down on what it describes as “unscrupulous” stem cell clinics selling unapproved treatments for eye problems like macular degeneration. Many people with fading vision have turned to stem cell therapy, believing it’s … |